Search - tctmd.com

Displaying 81 - 100 of 1300

Sort: Relevancy | Date

News Daily News

Más con Menos: Un Análisis de Rentabilidad Dice que Hay que Reducir en Dos Tercios el Precio de PCSK9

Yael L. Maxwell

August 29, 2016

News Conference News ESC 2016

Platelet Function Testing to Guide Treatment Does Not Benefit Elderly ACS Patients: ANTARCTIC

Todd Neale

August 28, 2016

News Conference News ESC 2016

NIPPON: With Nobori Stent, 6 Months of DAPT as Safe and Effective as 18 Months

Michael O'Riordan

August 28, 2016

Presentation ESC 2016

NIPPON Randomized Study: 6 Months vs 18 Months Dual Antiplatelet Treatment For Patients Underwent Bioabsorbable Polymer And Abluminal Coated DES Deployment

Presenter: Masato Nakamura

August 28, 2016

Presentation ESC 2016

ANTARCTIC: Assessment of a Normal vs Tailored Dose of Prasugrel After Stenting in 75 yo Patients to Reduce the Composite of Bleeding, Stent Thrombosis and Ischemic Complications

Presenter: Gilles Montalescot

August 28, 2016

News Conference News ESC 2016

Focus on LDL Cholesterol Targets With Statin Therapy, New ESC-EAS Cholesterol Guidelines Say

Michael O'Riordan

August 27, 2016

News Daily News

Noninvasive Testing Can Safely Spare a Large Proportion of Elderly Patients From Statin Therapy

Michael O'Riordan

August 23, 2016

Presentation

Impact Of Gender on 2-Year Clinical Outcomes in Patients Treated With 6- or 24-Month DAPT

Presenter: Giuseppe Gargiulo

August 19, 2016

News Daily News

Gender Should Not Factor Into DAPT Choice After PCI

L.A. McKeown

August 19, 2016

Presentation

Outcomes Among Older Stable Angina Patients Prescribed Beta-Blockers After PCI

Presenter: AA. Motivala

August 17, 2016

News Daily News

Beta-Blockers Not Beneficial After PCI for Stable Angina

Michael O'Riordan

August 17, 2016

Presentation

Warfarin and Antiplatelet Therapy vs Warfarin Alone for Treating Patients with A-fib Undergoing TAVR

Presenter: Abdul-Jawad Altisent

August 16, 2016

Presentation

Use of DAPT and Patient Outcomes in Those Undergoing PCI: The ROCKET AF Trial

Presenter: Matthew W. Sherwood

August 16, 2016

News Daily News

Improved Adherence to Medical Therapy Reduces CVD Events in Secondary Prevention Patients

Michael O'Riordan

August 16, 2016

News Daily News

冠脉内阿昔单抗显示对糖尿病 STEMI 患者有优势

L.A. McKeown

August 11, 2016

News Daily News

Intracoronary Abciximab Shows Advantage in Diabetic STEMI Patients

L.A. McKeown

August 11, 2016

News Daily News

El Abciximab Intracoronario es Beneficioso en Pacientes Diabéticos Víctimas de STEMI

L.A. McKeown

August 11, 2016

Presentation

Intracoronary Abciximab Shows Advantage in Diabetic STEMI Patients

Presenter: Raffaele Piccolo

August 10, 2016

Presentation

Prolonged High-Dose Bivalirudin Infusion Reduces Major Bleeding Without Increasing Stent Thrombosis in Patients Undergoing Primary PCI

Presenter: Gregor Fahrni

July 27, 2016

News Daily News

Another Meta-Analysis Supports Prolonged Bivalirudin Use in STEMI, but Is Contemporary PCI Reflected?

Yael L. Maxwell

July 27, 2016

Advertisement

Más con Menos: Un Análisis de Rentabilidad Dice que Hay que Reducir en Dos Tercios el Precio de PCSK9

Platelet Function Testing to Guide Treatment Does Not Benefit Elderly ACS Patients: ANTARCTIC

NIPPON: With Nobori Stent, 6 Months of DAPT as Safe and Effective as 18 Months

NIPPON Randomized Study: 6 Months vs 18 Months Dual Antiplatelet Treatment For Patients Underwent Bioabsorbable Polymer And Abluminal Coated DES Deployment

ANTARCTIC: Assessment of a Normal vs Tailored Dose of Prasugrel After Stenting in 75 yo Patients to Reduce the Composite of Bleeding, Stent Thrombosis and Ischemic Complications

Focus on LDL Cholesterol Targets With Statin Therapy, New ESC-EAS Cholesterol Guidelines Say

Noninvasive Testing Can Safely Spare a Large Proportion of Elderly Patients From Statin Therapy

Impact Of Gender on 2-Year Clinical Outcomes in Patients Treated With 6- or 24-Month DAPT

Gender Should Not Factor Into DAPT Choice After PCI

Outcomes Among Older Stable Angina Patients Prescribed Beta-Blockers After PCI

Beta-Blockers Not Beneficial After PCI for Stable Angina

Warfarin and Antiplatelet Therapy vs Warfarin Alone for Treating Patients with A-fib Undergoing TAVR

Use of DAPT and Patient Outcomes in Those Undergoing PCI: The ROCKET AF Trial

Improved Adherence to Medical Therapy Reduces CVD Events in Secondary Prevention Patients

冠脉内阿昔单抗显示对糖尿病 STEMI 患者有优势

Intracoronary Abciximab Shows Advantage in Diabetic STEMI Patients

El Abciximab Intracoronario es Beneficioso en Pacientes Diabéticos Víctimas de STEMI

Intracoronary Abciximab Shows Advantage in Diabetic STEMI Patients

Prolonged High-Dose Bivalirudin Infusion Reduces Major Bleeding Without Increasing Stent Thrombosis in Patients Undergoing Primary PCI

Another Meta-Analysis Supports Prolonged Bivalirudin Use in STEMI, but Is Contemporary PCI Reflected?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content